West Pharmaceutical Services, Inc.’s recent filing unveils that its VP & Treasurer Witherspoon Charles unloaded Company’s shares for reported $0.31 million on Aug 19 ’24. In the deal valued at $300.00 per share,1,029 shares were sold. As a result of this transaction, Witherspoon Charles now holds 1,478 shares worth roughly $0.44 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Hofmann Thomas W sold 617 shares, generating $225,773 in total proceeds. Upon selling the shares at $365.92, the Director now owns 43,565 shares.
Before that, Green Eric Mark sold 30,732 shares. West Pharmaceutical Services, Inc. shares valued at $9,364,409 were divested by the President, CEO and Board Chair at a price of $304.71 per share. As a result of the transaction, Green Eric Mark now holds 161,898 shares, worth roughly $47.75 million.
Jefferies upgraded its West Pharmaceutical Services, Inc. [WST] rating to a Buy from a a Hold in a research note published on February 07, 2024; the price target was increased to $536 from $323. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in mid June from “a Neutral” to “a Buy”. Stephens also remained covering WST and has increased its forecast on April 11, 2023 with a “an Overweight” recommendation from previously “an Equal-weight” rating. Deutsche Bank started covering the stock on December 14, 2022. It rated WST as “a Hold”.
Price Performance Review of WST
On Friday, West Pharmaceutical Services, Inc. [NYSE:WST] saw its stock jump 1.67% to $294.91. Over the last five days, the stock has lost -0.54%. West Pharmaceutical Services, Inc. shares have fallen nearly -16.25% since the year began. Nevertheless, the stocks have fallen -24.81% over the past one year. While a 52-week high of $413.70 was reached on 02/07/24, a 52-week low of $265.00 was recorded on 07/25/24. SMA at 50 days reached $300.17, while 200 days put it at $340.67.
Levels Of Support And Resistance For WST Stock
The 24-hour chart illustrates a support level at 288.30, which if violated will result in even more drops to 281.68. On the upside, there is a resistance level at 299.16. A further resistance level may holdings at 303.40. The Relative Strength Index (RSI) on the 14-day chart is 45.97, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -7.58, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 58.55%. Stochastics %K at 28.31% indicates the stock is a holding.
How much short interest is there in West Pharmaceutical Services, Inc.?
A steep rise in short interest was recorded in West Pharmaceutical Services, Inc. stocks on 2024-09-30, dropping by 83845.0 shares to a total of 1.44 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 1.53 million shares. There was a decline of -5.81%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 30, 2022 when UBS began covering the stock and recommended ‘”a Neutral”‘ rating along with a $250 price target.
